Related Experiment Video

Updated: Jun 10, 2026

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

PTK6 regulates IGF-1-induced anchorage-independent survival

Hanna Y Irie1, Yashaswi Shrestha, Laura M Selfors

  • 1Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, United States of America.

Plos One
|July 30, 2010
PubMed
Abstract

Insights

Protein tyrosine kinase 6 (PTK6) is crucial for tumor cell survival without anchorage, particularly in breast and ovarian cancers. Targeting PTK6 may offer new therapeutic strategies for these malignancies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Anchorage-independent survival is vital for tumor cell dissemination and is often driven by growth factor receptor hyperactivation.
  • Identifying key regulators of this process is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To identify molecules that critically regulate insulin-like growth factor 1 (IGF-1)-induced anchorage-independent survival.

Main Methods:

  • High-throughput siRNA screening was employed to identify critical regulators.
  • Reverse-phase protein arrays and subsequent analyses were used to elucidate molecular mechanisms.

Main Results:

  • PTK6 was identified as essential for IGF-1 receptor (IGF-1R)-mediated anchorage-independent survival in mammary epithelial cells.
  • PTK6 downregulation induced apoptosis in matrix-deprived breast and ovarian cancer cells, while overexpression promoted survival.
  • PTK6 interacts with IGF-1R and IRS-1, regulating IGF-1R expression and phosphorylation.
  • High PTK6 expression correlates with poor outcomes in Her2(+) and Luminal B breast cancer subtypes.

Conclusions:

  • PTK6 critically regulates anchorage-independent survival in breast and ovarian tumor cells by modulating IGF-1 receptor signaling.
  • PTK6 represents a potential therapeutic target for various tumor types.
  • Combined genomic and proteomic approaches effectively identify oncogenes and their mechanisms.

More Related Videos

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...